BenevolentAI

BenevolentAI

AI-first drug discovery company applying machine learning and knowledge graphs to identify novel drug targets and accelerate clinical development.

HeadquartersLondon, UK
Founded2013
FounderKenneth Mulvany
Employees200–499
StockN/A
OwnershipPrivate
Geographic PresenceEurope|North America
HiringHiring
Innovation LevelHigh
Commercialisation StageClinical Stage
Africa PresenceYes
×